Clinical disparity of elevated serum alanine aminotransferase (ALT) levels among the working population of Taipei, Taiwan

Abstract

Purpose: To explore sex variations in the prevalence and factors of high serum alanine aminotransferase (ALT) level among the working population in Taipei, Taiwan.

Methods: This study included 8,351 healthy adults (5,247 men and 3,104 women) who admitted to a teaching hospital voluntarily for a physical examination in 2009. The definitions of occupations include computer and mathematical occupations, architecture and engineering occupations, community and social service occupations, sales and related occupations, office and administrative support occupations, and production occupations. The age distribution of ≤ 29 yrs, 30-39 yrs, 40-49 yrs, and ≥ 50 yrs were 22.5%, 36.8%, 23.5%, and 17.2%, respectively. Fasting blood samples were drawn using venipuncture and participants were interviewed with a structured questionnaire.

Results: The overall prevalence of high serum ALT level (≥ 40 U/L) was 17.1%. After stratified the data according to age into four age groups (≤ 29 yrs, 30-39 yrs, 40-49 yrs, and ≥ 50 yrs), the men participants revealed a higher prevalence of high serum ALT levels for all age groups than the women participants. Bases on multiple logistic regression models, for the men, the significant factors were associated with high serum ALT level and included age (OR = 0.96, 95% CI: 0.95-097), BMI [no matter whether overweight (OR = 2.45, 95% CI: 1.99-3.02) or obese (OR = 4.02, 95% CI: 3.22-5.03)], hypercholesterolemia (yes vs. no, OR = 1.25, 95% CI: 1.05-1.48), hypertriglyceridemia (OR = 1.25, 95% CI: 1.04-1.50), high FPG levels (OR = 1.48, 95% CI: 1.05-2.09), high AST levels (OR = 26.71, 95% CI: 19.00-37.54), hyperuricemia (OR = 1.48, 95% CI: 1.25-1.76), high ALP levels (OR = 1.20, 95% CI: 1.00-1.45), and high glutamic acid transaminase levels (OR = 4.31, 95% CI: 3.61-5.14). For the women subjects, the statistically significant factors that were associated with high serum ALT level included BMI [no matter whether overweight (OR = 3.53, 95% CI: 1.87-6.67) or obese (OR = 4.32, 95% CI: 2.26-8.23)], high AST levels (yes vs. no, OR = 38.49, 95% CI: 21.45-49.28), high BUN levels (yes vs. no, OR = 1.66, 95% CI: 1.03-2.29), and high glutamic acid transaminase levels (yes vs. no, OR = 9.87, 95% CI: 5.79-16.83).

Conclusion: In conclusion, the clinical problem of elevated serum ALT level is important in the working population. Many subjects are asymptomatic and the diagnosis of high serum ALT level should be considered with sex, age, hyperuricemia, high AST levels, high ALP levels, high glutamic acid transaminase levels, and metabolic risk factors in mind.

Keywords

Serum alanine aminotransferase / Prevalence / Gender difference / Working population

References

[1] Liu CM, Tung TH, Liu JH, et al. A community-based epidemiological study of elevated serum alanine aminotransferase levels in Kinmen, Taiwan. World J Gastroenterol. 2005; 11: 1616-1622. https://doi.org/10.3748/wjg.v11.i11.1616

[2] Chen CH, Huang MH, Yang JC, et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol. 2007; 22: 1482-1489. PMid:17716352. https://doi.org/10.1111/j.1440-1746.2006.04615.x

[3] Dong MH, Bettencourt R, Barrett-Connor E, et al. Alanine Aminotransferase Decreases with Age: The Rancho Bernardo Study. PLoS ONE. 2010; 5: e14254.

[4] Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet. 1988; 2: 1267-1273. https://doi.org/10.1016/S0140-6736(88)92890-5

[5] Wang JJ, Tung TH, Yin WH, et al. Effects of moderate alcohol consumption on inflammatory biomarkers. Acta Cardiol. 2008; 63: 65-72. PMid:18372583. https://doi.org/10.2143/AC.63.1.2025334

[6] Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes. Hepatology. 2008; 44: 792-8. PMid:18752331. https://doi.org/10.1002/hep.22429

[7] Tsai CH, Lee YC, Ro YC, et al. Non-alcoholic fatty liver disease and obesity-associated factors: A study in a regional hospital in Mid-Taiwan. Taiwan J Fam Med. 2006; 16: 215-25.

[8] Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006; 105: 626-635. https://doi.org/10.1016/S0929-6646(09)60161-3

[9] Caballería L, Auladell MA, Torán P, et al. Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study. BMC Gastroenterology. 2008; 8: 44-50.

[10] Chen ZW, Chen LY, Dai HL, et al. Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease. J Zhejiang Univ Sci B. 2008; 9: 616-622. PMid:18763311. https://doi.org/10.1631/jzus.B0720016

[11] Poustchi H, George J, Esmaili S, et al. Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. PLoS ONE. 2011; 6: e21178. https://doi.org/10.1371/journal.pone.0021178

[12] Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterology. 2003; 98: 960-967. PMid:12809815. https://doi.org/10.1111/j.1572-0241.2003.07486.x

[13] Zhang H, Ding Y, Li Q, et al. Relationship between serum aminotransferase levels and metabolic disorders in Northern China. Iran J Public Health. 2012; 41: 15-26.

[14] Oh SY, Cho YK, Kang MS, et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism. 2006; 55: 1604-1609. PMid:17142131. https://doi.org/10.1016/j.metabol.2006.07.021

[15] Wang CS, Wang ST, Chou P. Using the prevalence of an elevated serum alanine aminotransferase level for identifying communities with a high prevalence of hepatitis C virus infection. Arch Intern Med. 2001; 161: 392-394. https://doi.org/10.1001/archinte.161.3.392

[16] Pan JJ, Qu HQ, Rentfro A, et al. Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: A population-based study. PLoS ONE. 2011; 6: e21515.

[17] Kallwitz ER, Kumar M, Aggarwal R, et al. Ethnicity and non-alcoholic fatty liver disease in an obesity clinic: the impact of triglycerides. Dig Dis Sci. 2008; 53: 1358-1363. PMid:18347982. https://doi.org/10.1007/s10620-008-0234-x

[18] Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol. 2002; 17: 1098-1105. https://doi.org/10.1046/j.1440-1746.2002.02846.x

[19] Kariv R, Leshno M, Beth-Or A, et al. Re-evaluation of serum alanine aminotransferase upper limit and its modulation factors in a large-scale population study. Liver International. 2006; 26: 445-450. PMid:16629648. https://doi.org/10.1111/j.1478-3231.2006.01197.x

[20] Elinav E, Ben-Dov IZ, Ackerman E, et al. Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern. Am J Gastroenterol. 2005; 100: 2201-2204. PMid:16181369. https://doi.org/10.1111/j.1572-0241.2005.41822.x

[21] Le Couteur DG, Blyth FM, Creasey HM, et al. The association of alanine transaminase with aging, frailty, and mortality. J Gerontol A Biol Sci Med Sci. 2010; 65: 712-717. PMid:20498223. https://doi.org/10.1093/gerona/glq082

[22] Fu CC, Chen MC, Li YM, et al. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. Ann Acad Med Singapore. 2009; 38: 15-17.

[23] Chen SCC, Yeh JJ, Chang MH, et al. Gender difference of alanine aminotransferase elevation may be associated with higher hemoglobin levels among Male Adolescents. PLoS ONE. 2010; 5: e13269.

[24] Fan JG, Peng YD. Metabolic syndrome and non-alcoholic fatty liver disease: Asia definitions and Asian studies. Hepatobiliary Pancreat Dis Int. 2007; 6: 572-578. PMid:18086620.

[25] Vozarova B, Stefan N, Lindsay RS, et al. High alanine aminotransferase is associated with decrease hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002; 51: 1889-1895. https://doi.org/10.2337/diabetes.51.6.1889

[26] Bruckert E, Giral P, Ratziu V, et al. A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Metabolism. 2002; 51: 1071-1076. https://doi.org/10.1053/meta.2002.34046

[27] Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2005; 128: 24-32. https://doi.org/10.1053/j.gastro.2004.09.075